CHEARS News Room

This is News Broadcast Room of CHEARS.
Our purpose is to create awareness among general public through the various health news updates and interventional updates from the sector of healthcare. This News Room works under Dr. Keerthana Ramesh, Chief Editor, Department of CNAR, CHEAARS.

Warning to Website Operators Illegally Selling Opioids

19 September 2020

he U.S. Food and Drug Administration has issued warning letters to 17 website operators for illegally selling unapproved and misbranded opioids online in violation of the Federal Food, Drug, and Cosmetic Act. Misbranded opioids include those offered for sale without a prescription, as well as opioids that lack adequate directions for use.

The opioids offered for sale include products such as tramadol and oxycodone. These are prescription drugs that have significant risks of addiction, abuse and misuse, which can lead to overdose and death, and should only be used under the supervision of a licensed health care provider. These warning letters are a continuation of the FDA’s commitment to take action against the illegal sale of opioids over the internet.

The warning letters were issued to:

  • alpharoyalpharmacy.com

  • beststeroidstore.net

  • bluepillmedications.com

  • buydrugsmedsonline.com

  • genericpharmacyusa.com

  • globalpharmacystores.com

  • greenrxpharmacy.com

  • klasiekpharmacy.com

  • lekapharma.com

  • mega-pillspharmacy.com

  • melanopharmacy.com

  • roidsforce.com

  • rxeasymeds.com

  • skylimitpharmacy.com

  • Thomas Meds

  • uspharmacyshop.com

  • xsteroids.com

In addition to the significant risks of addiction, abuse and misuse, opioids can cause life-threatening respiratory depression (breathing problems), which can lead to overdose and death, and withdrawal symptoms in newborn babies. When taken with other central nervous system depressants, including alcohol, the use of opioids may result in coma or death.

9
It will be great, if you share your view on above write-up. 

Your content has been submitted. Please refresh page to see comment

 Combination for Treating Mesothelioma Approved

CHEARS News Room

12 October 2020

Combination for Treating Mesothelioma Approved

COVID-19 and its impact on snakebite care in India: a bane or a boon?

CHEARS News Room

13 August 2020

COVID-19 and its impact on snakebite care in India: a bane or a boon?

Eli Lilly antibody trial paused over safety concern

CHEARS News Room

14 October 2020

Eli Lilly antibody trial paused over safety concern